Janux Therapeutics JANX
NASDAQ JANX
$12.04 -0.72 (-5.64%)
As of: Nov 10, 2026 · 2:21 PM EST

Janux Therapeutics (JANX) Operating Expenses (2020 - 2026)

Updated

Janux Therapeutics' Operating Expenses was $41.96 million in Q2 2026, down 7.0% from $45.12 million a year earlier but up 10.6% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Operating Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Janux Therapeutics' Operating Expenses was $167.56 million through Jun 30, 2026, up 15.3% year-over-year; for FY2025, it came in at $167.67 million, up 53.2% from FY2024.

  • Operating Expenses has now increased for five consecutive years, with a five-year compound annual growth rate of 103.2% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $109.44 million in FY2024 (+35.0%), $81.06 million in FY2023 (+7.1%), $75.7 million in FY2022 (+107.0%) and $36.57 million in FY2021 (+655.0%).
  • Quarterly Operating Expenses has moved between $12.06 million (Q3 2021) and $45.25 million (Q3 2025) over five years.
  • Compared with a year earlier, Operating Expenses was higher in seven of the last eight quarters, with growth averaging 48.5%.
  • The best year-over-year quarter for Operating Expenses over five years was Q3 2021 (growth of 860.4%); the worst was Q4 2023 (a decline of 11.9%).
  • Per Business Quant data, JANX's Operating Expenses in the three quarters before Q2 2026 was $37.95 million (Q1 2026), $42.4 million (Q4 2025) and $45.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 7.68 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 11.12 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 11.14 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.61 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 9.70 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 4.84 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 7.09 Bn
10 Janux Therapeutics 771.59 Mn -3.07 Bn - 40.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 40.55 Mn
Jun 30, 2026 41.96 Mn
Mar 31, 2026 37.95 Mn
Dec 31, 2025 42.40 Mn
Sep 30, 2025 45.25 Mn
Jun 30, 2025 45.12 Mn
Mar 31, 2025 34.90 Mn
Dec 31, 2024 29.02 Mn
Sep 30, 2024 36.28 Mn
Jun 30, 2024 22.72 Mn
Mar 31, 2024 21.41 Mn
Dec 31, 2023 18.60 Mn
Sep 30, 2023 18.33 Mn
Jun 30, 2023 21.81 Mn
Mar 31, 2023 22.33 Mn
Dec 31, 2022 21.11 Mn
Sep 30, 2022 19.84 Mn
Jun 30, 2022 19.63 Mn
Mar 31, 2022 15.13 Mn
Dec 31, 2021 15.11 Mn
API Access

Janux Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=JANX&period=max&api_key=YOUR_API_KEY